CNS Clinical Trials
€ 46,90
Envio em 4/5 dias
Informação do Produto
| ISBN | 9780309148832 |
|---|---|
| Autores | Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Institute of Medicine |
| Editora | National Academies Press |
| Formato | Capa mole |
| Número de páginas | 88 |
| Peso (kg) | 0,168 |
| Data de Publicação | 22/12/2010 |
| Preço (iva excl.) | € 44,25 |
| Imposto | € 2,65 |
| Preço (iva inc.) | € 46,90 |
| Disponibilidade | 1 unidade em armazém externo |
Descrição do Produto
The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA's new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future.